Research Study for Patients With Metastatic Renal Cell Carcinoma

Status:
Terminated

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

This study has been designed to study patients diagnosed with advanced renal cell cancer with the primary tumor in place.

Phase 2

Bayer

Sorafenib